Studies have suggested that IL-1 beta activation leads to IL-6 production, which could provide an alternative to current therapeutic strategies.

A recent analysis of the LoDoCo2 (Low-Dose Colchicine 2) trial suggests that taking a low daily dose of colchicine may reduce ...

Many influencers claim the medical community ignores inflammation, but countless millions have been spent studying the ...

4) CLEAR SYNERGY, dual trials on the use of spironolactone vs. placebo and colchicine vs. placebo in patients with myocardial infarction, and 5) Project My Heart Your Heart, developing a protocol of ...

Mandibular advancement devices (MAD) are noninferior to continuous positive airway pressure (CPAP) for lowering mean arterial blood pressure (MABP) in patients with moderate-to-severe obstructive ...

TUESDAY, Nov. 19, 2024 (HealthDay News) -- Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), according to a study presented at ...

Colchicine, an ancient drug with a well-established safety record, that is now approved for secondary prevention of atherosclerosis based upon its proven efficacy and safety. In a recent meta-analysis ...